What roles does Thomas Joeseph Carrico hold at Neuraxis (NRXS) related to this RSU grant?

Thomas Joeseph Carrico is reported as an officer of Neuraxis, serving as CRO, CCO, and CPO . The 135,906 RSU grant represents stock-based compensation associated with his executive roles under the 2022 Omnibus Securities and Incentive Plan.

Neuraxis (NRXS) grants CRO 135,906 RSUs vesting over 3 years

Q: What did Neuraxis (NRXS) disclose about Thomas Joeseph Carrico’s recent equity award?

Neuraxis disclosed that officer Thomas Joeseph Carrico received a grant of 135,906 restricted stock units (RSUs) . The award was made as compensation under the company’s 2022 Omnibus Securities and Incentive Plan and is tied to Neuraxis common stock.

Q: How many RSUs did NRXS grant to Thomas Joeseph Carrico and at what value?

Neuraxis granted 135,906 RSUs to Thomas Joeseph Carrico at a reported value of $6.28 per unit . These RSUs represent an equivalent number of shares of Neuraxis common stock upon vesting under the company’s equity incentive plan.

Q: What is the vesting schedule for Thomas Joeseph Carrico’s RSUs at Neuraxis (NRXS)?

Carrico’s 135,906 RSUs vest in three equal annual installments over a three-year period . This means one-third of the units will vest each year, subject to the terms and conditions of Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan.

Q: Under which plan were the RSUs granted to the Neuraxis (NRXS) officer?

The RSUs were granted under the Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan, as amended . This plan governs the company’s stock-based compensation awards, including restricted stock units issued to officers such as Thomas Joeseph Carrico.

Q: What is Thomas Joeseph Carrico’s RSU holding in Neuraxis (NRXS) after this grant?

Following the grant, Carrico directly holds 135,906 RSUs linked to Neuraxis common stock. The reported post-transaction balance equals the newly granted amount, reflecting his current position in these restricted stock units under the company’s incentive plan.

Filing Impact

(Very High)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Carrico Thomas Joeseph reported acquisition or exercise transactions in this Form 4 filing.

Neuraxis, Inc. reported that officer Thomas Joeseph Carrico received a grant of 135,906 RSUs of common stock as compensation under the Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan. The RSUs, valued at $6.28 per unit, vest in three equal annual installments over a three-year period, and Carrico now directly holds 135,906 RSUs.

Insights

Analyzing...

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Carrico Thomas Joeseph

Role CRO, CCO, CPO

Type	Security	Shares	Price	Value
Grant/Award	RSU ^F1	135,906	$6.28	$853K

Holdings After Transaction: RSU — 135,906 shares (Direct)

Footnotes (1)

F1. These shares of common stock are restricted stock units (RSUs) granted to the reporting person as compensation under Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan, as amended. The RSUs vest in three equal annual installments over a three-year period.

Key Figures

RSUs granted: 135,906 Per-unit value: $6.28 per RSU RSUs following transaction: 135,906 +2 more

5 metrics

RSUs granted 135,906 Restricted stock units granted to officer on 2026-08-13

Per-unit value $6.28 per RSU Reported transaction price per RSU for the grant

RSUs following transaction 135,906 Total RSUs directly held by Carrico after the grant

Vesting period 3 years RSUs vest in three equal annual installments over a three-year period

Annual vesting installments 3 Three equal annual vesting tranches for the RSU award

Key Terms

restricted stock units (RSUs), 2022 Omnibus Securities and Incentive Plan, vesting

3 terms

restricted stock units (RSUs) financial

"These shares of common stock are restricted stock units (RSUs) granted"

Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.

2022 Omnibus Securities and Incentive Plan financial

"as compensation under Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan"

vesting financial

"The RSUs vest in three equal annual installments over a three-year period"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

FAQ

What did Neuraxis (NRXS) disclose about Thomas Joeseph Carrico’s recent equity award?

Neuraxis disclosed that officer Thomas Joeseph Carrico received a grant of 135,906 restricted stock units (RSUs). The award was made as compensation under the company’s 2022 Omnibus Securities and Incentive Plan and is tied to Neuraxis common stock.

How many RSUs did NRXS grant to Thomas Joeseph Carrico and at what value?

Neuraxis granted 135,906 RSUs to Thomas Joeseph Carrico at a reported value of $6.28 per unit. These RSUs represent an equivalent number of shares of Neuraxis common stock upon vesting under the company’s equity incentive plan.

What is the vesting schedule for Thomas Joeseph Carrico’s RSUs at Neuraxis (NRXS)?

Carrico’s 135,906 RSUs vest in three equal annual installments over a three-year period. This means one-third of the units will vest each year, subject to the terms and conditions of Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan.

Under which plan were the RSUs granted to the Neuraxis (NRXS) officer?

The RSUs were granted under the Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan, as amended. This plan governs the company’s stock-based compensation awards, including restricted stock units issued to officers such as Thomas Joeseph Carrico.

What is Thomas Joeseph Carrico’s RSU holding in Neuraxis (NRXS) after this grant?

Following the grant, Carrico directly holds 135,906 RSUs linked to Neuraxis common stock. The reported post-transaction balance equals the newly granted amount, reflecting his current position in these restricted stock units under the company’s incentive plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/17/2026 - 06:27 PM Accepted by SEC EDGAR 08/17/2026 - 06:27 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Carrico Thomas Joeseph

(Last)

(First)

(Middle)

11611 N. MERIDIAN ST,

SUITE 330

(Street)

CARMEL

INDIANA

46032

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Neuraxis, INC [ NRXS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	CRO, CCO, CPO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/13/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
RSU	⁽¹⁾	08/13/2026		A		135,906		⁽¹⁾	⁽¹⁾	Common Stock	135,906	$6.28	135,906	D

Explanation of Responses:

1. These shares of common stock are restricted stock units (RSUs) granted to the reporting person as compensation under Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan, as amended. The RSUs vest in three equal annual installments over a three-year period.

	/s/ Thomas Carrico	08/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR